Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Bosentan

A dual endothelin receptor antagonist (ETA and ETB), approved in the United States in 2001: it is taken by mouth and used to treat pulmonary arterial hypertension. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?Its target, endothelin, a powerful vasoconstrictor peptide made by the cells lining blood vessels, was only discovered in 1988 by Masashi Yanagisawa, then a graduate student at the University of Tsukuba.

BosentanGo to the active ingredient →
BosentanActive ingredientBosentanCat. No. P-B100-001CAS 147536-97-8
Bosentan-d4Isotopically labelledBosentan-d4Cat. No. P-B100-008CAS 1065472-77-6

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.